Hormone therapy for preventing cardiovascular disease in post-menopausal women-Reference-Cited by-同舟云学术

Hormone therapy for preventing cardiovascular disease in post-menopausal women

Published:2015-03-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Boardman Henry MP¹,Hartley Louise²,Eisinga Anne³,Main Caroline⁴,Roqué i Figuls Marta⁵,Bonfill Cosp Xavier⁶,Gabriel Sanchez Rafael⁷,Knight Beatrice⁸

Affiliation:

1. University of Oxford, John Radcliffe Hospital; Department of Cardiovascular Medicine; Oxford UK OX3 9DU

2. Warwick Medical School, University of Warwick; Division of Health Sciences; Coventry Warwickshire UK CV4 7AL

3. UK Cochrane Centre; National Institute for Health Research Summertown Pavilion, Middle Way Oxford Oxfordshire UK OX2 7LG

4. University of Birmingham; Cancer Research UK Clinical Trials Unit (CRCTU), School of Cancer Sciences; Birmingham UK B15 2TT

5. CIBER Epidemiología y Salud Pública (CIBERESP); Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 171 Edifici Casa de Convalescència Barcelona Catalunya Spain 08041

6. CIBER Epidemiología y Salud Pública (CIBERESP) - Universitat Autònoma de Barcelona; Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret, 167 Pavilion 18 (D-13) Barcelona Catalunya Spain 08025

7. Hospital Universitario de la Paz, Universidad Autónoma de Madrid; Instituto de Investigacion IdiPAZ, Red Espanola de Investigacion Cardiovascular RD/12/0042/0008; Diego De Leon 62 Planta 9 Madrid Spain 28006

8. University of Exeter Medical School; NIHR Exeter Clinical Research Facility; Exeter UK

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD002229.pub4/fullpdf

Reference219 articles.

1. Effect of long-term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study;Bladbjerg;Journal of Thrombosis and Haemostasis,2003

2. Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: results from the Danish Osteoporosis Prevention Study (DOPS);Kristensen;Thrombosis and Haemostasis,2006

3. Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women;Madsen;Journal of Thrombosis and Haemostasis,2003

4. Hormone replacement treatment in early postmenopausal women reduces cardiovascular events - A randomized controlled study;Schierbeck;Circulation,2011

5. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial;Schierbeck;BMJ,2012

Cited by 367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prior pre-eclampsia does not diminish the vascular protective effect of menopausal hormone therapy;Maturitas;2024-11

2. Menopause and MHT in 2024: addressing the key controversies – an International Menopause Society White Paper;Climacteric;2024-09-13

3. Role of Hormones over the Lifespan: How Hormone Balance Affects General Health and Well-Being at All Ages;Women's Health Problems - A Global Perspective;2024-09-11

4. Age-related trends of ischemic sudden cardiac death in women;International Journal of Cardiology;2024-09

5. Primary Prevention of Coronary and Other Cardiovascular Diseases: A Focused Review;Journal of Atherosclerosis and Thrombosis;2024-08-01